Charlyse Herrmann

Charlyse Herrmann is an accomplished professional in the field of pharmaceutical formulation and preclinical galenics, currently serving as Senior Lab Head at Idorsia Pharmaceuticals Ltd since June 2017. With a strong background in preclinical formulation development, Charlyse specializes in strategies for animal pharmacokinetics, pharmacology, and safety studies, alongside expertise in physico-chemical characterization techniques. Prior experience includes a Lab Head role at Actelion from October 2010 to June 2017, where Charlyse focused on formulating liquid oral dosage forms and iv formulations for toxicity studies, utilizing advanced nanoformulation technologies and analytical methods. Earlier professional training involved positions at Servier and CNRS, where Charlyse contributed to innovative formulation projects. Charlyse holds a PharmD and a Master of Science in Pharmaceutical Engineering from Université Louis Pasteur (Strasbourg I).